Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
inotuzumab ozogamicin b-cell receptor cd22 biotech Successful target TTD , drugbank , DGIDB Relapse[MeSHID:D012008]
Burkitt Lymphoma[MeSHID:D002051]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]		 NA approved,investigational antibody
inotuzumab ozogamicin b-cell receptor cd22 biotech Successful target TTD , drugbank , DGIDB Relapse[MeSHID:D012008]
Burkitt Lymphoma[MeSHID:D002051]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198]		 21.22 approved,investigational antibody
click here to return to the previous page